Cargando…
Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling
BACKGROUND: Arhalofenate acid, the active acid form of arhalofenate, is a non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand, with uricosuric activity via URAT1 inhibition. Phase II studies revealed decreased acute arthritis flares in arhalofenate-treated gout compared with allo...
Autores principales: | McWherter, Charles, Choi, Yun-Jung, Serrano, Ramon L., Mahata, Sushil K., Terkeltaub, Robert, Liu-Bryan, Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127987/ https://www.ncbi.nlm.nih.gov/pubmed/30189890 http://dx.doi.org/10.1186/s13075-018-1699-4 |
Ejemplares similares
-
Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis
por: Piancone, Federica, et al.
Publicado: (2018) -
Monosodium urate crystals induce oxidative stress in human synoviocytes
por: Zamudio-Cuevas, Yessica, et al.
Publicado: (2016) -
The Role of Inhibitory Receptors in Monosodium Urate Crystal-Induced Inflammation
por: Fernandes, Maria J., et al.
Publicado: (2018) -
Cynarin suppresses gouty arthritis induced by monosodium urate crystals
por: Wu, Changgui, et al.
Publicado: (2022) -
A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout
por: Poiley, Jeffrey, et al.
Publicado: (2016)